XML 47 R40.htm IDEA: XBRL DOCUMENT v3.25.3
Fair Value Measurements of Financial Instruments (Tables)
9 Months Ended
Sep. 30, 2025
Fair Value Disclosures [Abstract]  
Schedule of Carrying Amounts and Fair Values of Financial Instruments

The carrying amounts and fair values of the Company’s financial instruments as of September 30, 2025, are presented below (in thousands):

 

 

 

Fair Value Measurements

 

 

 

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Money market accounts(1)

 

$

7,853

 

 

$

 

 

$

 

 

$

7,853

 

Marketable securities

 

 

1,221

 

 

 

 

 

 

 

 

 

1,221

 

Total assets

 

$

9,074

 

 

$

 

 

$

 

 

$

9,074

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Sun Labs remaining equity interest purchase

 

$

 

 

$

 

 

$

7,352

 

 

$

7,352

 

CFC contingent consideration

 

 

 

 

 

 

 

 

7,023

 

 

 

7,023

 

CHS contingent consideration

 

 

 

 

 

 

 

 

6,568

 

 

 

6,568

 

Other(2)

 

 

 

 

 

808

 

 

 

15

 

 

 

823

 

Total liabilities

 

$

 

 

$

808

 

 

$

20,958

 

 

$

21,766

 

(1)
Included in cash and cash equivalents.
(2)
Other consists of the interest rate collar, other contingent consideration liabilities, and the interest rate swap.

The carrying amounts and fair values of the Company’s financial instruments as of December 31, 2024, are presented below (in thousands):

 

 

Fair Value Measurements

 

 

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Money market accounts(1)

 

$

3,673

 

 

$

 

 

$

 

 

$

3,673

 

Marketable securities

 

 

2,378

 

 

 

 

 

 

 

 

 

2,378

 

I Health call option

 

 

 

 

 

 

 

 

3,778

 

 

 

3,778

 

Interest rate collar

 

 

 

 

 

19

 

 

 

 

 

 

19

 

Total assets

 

$

6,051

 

 

$

19

 

 

$

3,778

 

 

$

9,848

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Sun Labs remaining equity interest purchase

 

$

 

 

$

 

 

$

7,352

 

 

$

7,352

 

ADSC contingent consideration

 

 

 

 

 

 

 

 

4,285

 

 

 

4,285

 

CFC contingent consideration

 

 

 

 

 

 

 

 

9,949

 

 

 

9,949

 

CHS contingent consideration

 

 

 

 

 

 

 

 

5,643

 

 

 

5,643

 

Other(2)

 

 

2,110

 

 

 

 

 

 

1,366

 

 

 

3,476

 

Total liabilities

 

$

2,110

 

 

$

 

 

$

28,595

 

 

$

30,705

 

(1)
Included in cash and cash equivalents.
(2)
Other consists of other contingent consideration liabilities.
Schedule of Change in Fair Value of Level 3 Liabilities

The change in the fair value of Level 3 liabilities is recognized in other income or general and administrative expenses in the accompanying condensed consolidated statements of income. As of September 30, 2025, the reconciliation of our Level 3 liabilities was as follows (in thousands):

 

 

Amount

 

Balance at January 1, 2025

 

$

28,595

 

Change in fair value of existing Level 3 liabilities

 

 

3,863

 

Settlement

 

 

(11,500

)

Balance at September 30, 2025

 

$

20,958